Last reviewed · How we verify
Kristalose
At a glance
| Generic name | Kristalose |
|---|---|
| Sponsor | Benaroya Research Institute |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial) (NA)
- Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy
- Evaluation of the Outcome of Fecal Microbiota Transplantation (PHASE1, PHASE2)
- Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy (PHASE1, PHASE2)
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
- Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure. (NA)
- Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients (PHASE4)
- New Mechanisms of Obesity (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kristalose CI brief — competitive landscape report
- Kristalose updates RSS · CI watch RSS
- Benaroya Research Institute portfolio CI